https://www.selleckchem.com/pr....oducts/cd38-inhibito
242), KOOS-PS (p = 0.088), VR-12 PCS (p 0.2757), VR-12 MCS scores (p 0.075)]. There were statistically significant baseline differences between responders and non-responders (patients lost to follow-up), but differences were small and not clinically relevant. PROMs were not significantly different between 1- and 2-year time points for THA and TKA. Minimal demographic or baseline differences between responders and non-responders suggest a representative sample. These data support a minimum follow-up of 1year for studie
Like
Comment
Share
